Endocrine Abstracts

Based on insights obtained during the last decade, the classical concept of an activated hypothalamus-pituitary-adrenocortical (HPA) axis in response to critical illness is in need of revision. After a brief central HPA axis activation, the vital maintenance of increased systemic cortisol availability and action in response to critical illness is predominantly driven by peripheral adaptations rather than by an ongoing centrally-activated several-fold increased production and secretion of cortisol. Besides the known reduction of cortisol binding proteins that increases free cortisol, these peripheral responses comprise suppressed cortisol metabolism in liver and kidney, prolonging cortisol half-life, and local alterations in expression of 11βHSD1, GRα and FKBP51 that appear to titrate increased GRα-action in vital organs and tissues while reducing GRα-action in neutrophils possibly preventing immune-suppressive side effects of increased systemic cortisol availability. Peripherally increased cortisol can exert negative feed-back inhibition at the pituitary level impairing processing of POMC into ACTH and reducing ACTH-driven cortisol secretion, while ongoing central activation explains increased circulating POMC. These alterations are likely adaptive and beneficial for the host in the short term. However, as a consequence, patients with prolonged critical illness who require intensive care for weeks or longer may develop a form of central adrenal insufficiency. The new insights challenge the validity of earlier concepts such as “relative”, as opposed to “absolute”, adrenal insufficiency and generalized systemic glucocorticoid resistance in the critically ill. They also question the scientific basis for broad implementation of stress dose hydrocortisone treatment of patients suffering from acute septic shock solely based on assumption of cortisol insufficiency.